These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3316024)

  • 21. Comparison of plateletpheresis using two cell separators and identical donors.
    Bertholf MF; Mintz PD
    Transfusion; 1989; 29(6):521-3. PubMed ID: 2749875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Side effects in plasma exchange (PE) and therapeutic cytapheresis (TCP)].
    Höcker P; Wagner A; Hofer M; Spreng S; Pittermann E
    Beitr Infusionther Klin Ernahr; 1987; 18():234-7. PubMed ID: 3439981
    [No Abstract]   [Full Text] [Related]  

  • 23. Improvement of the safety systems in cell separators. The new safety concept for the cell separator AS 104 (Fresenius).
    Neumann HJ; Meisberger A; Mathieu B
    Infusionsther Klin Ernahr; 1987 Sep; 14 Suppl 4():43-51. PubMed ID: 3316023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Therapeutic cytapheresis].
    Wiebecke D; Gunzer U; Ullrich H; Kadar J
    Beitr Infusionsther; 1991; 28():226-32. PubMed ID: 1725627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plateletapheresis using single vein access: a comparison of Haemonetics V-50 and Fenwal CS-3000 blood cell separators.
    Vados W; Thompson H; Scott E
    Vox Sang; 1987; 52(3):195-9. PubMed ID: 3604178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of two new filtration systems--Fenwal PS400 and Organon Teknika Curesis--and comparison of results with two centrifugation systems--IBM model 2997 and Haemonetics V50.
    Coffe C; Couteret Y; Pujol JP; Kieffer Y; Lenys R; Panouse J; Peters A
    Int J Artif Organs; 1985 Jul; 8 Suppl 2():43-8. PubMed ID: 4055112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Techniques, indications, and toxicity of therapeutic hemapheresis in children.
    Kasprisin DO
    J Clin Apher; 1989; 5(1):21-4. PubMed ID: 2777736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effectiveness of different methods of blood separation in performing plasma- and cytapheresis].
    Ryzhko VV; Gorodetskiĭ VM; Rogova EM
    Ter Arkh; 1988; 60(5):85-8. PubMed ID: 3175936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Experiences with autologous donation and transfusion equipment].
    Mehrkens HH; Geiger P; Weindler M; Wollinsky KH; Pohland H
    Beitr Infusionsther; 1991; 28():274-82. PubMed ID: 1725638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biocompatibility and safety of cytapheresis.
    Kretschmer V; Söhngen D; Göddecke W; Kadar JG; Pelzer H; Prinz H; Eckle R
    Infusionstherapie; 1989 Aug; 16 Suppl 2():10-20; discussion 28-9. PubMed ID: 2583840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Complications in therapeutic cytapheresis and plasma exchange treatments].
    Ullrich H; Wiebecke D; Hohe R; Gunzer U; Mansouri-Taleghani B
    Beitr Infusionther Klin Ernahr; 1987; 18():241-3. PubMed ID: 3439983
    [No Abstract]   [Full Text] [Related]  

  • 32. Blood component collection by apheresis.
    Burgstaler EA
    J Clin Apher; 2006 Jul; 21(2):142-51. PubMed ID: 15880369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequency of immediate adverse effects associated with apheresis donation.
    McLeod BC; Price TH; Owen H; Ciavarella D; Sniecinski I; Randels MJ; Smith JW
    Transfusion; 1998 Oct; 38(10):938-43. PubMed ID: 9767744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multicomponent collection (MCC) with the latest hemapheresis apparatuses.
    Valbonesi M; Florio G; Ruzzenenti MR; Bo A; Bruni R; Giannini G; Morelli F
    Int J Artif Organs; 1999 Jul; 22(7):511-5. PubMed ID: 10493560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Side effects of hemapheresis.
    Boogaerts MA
    Transfus Med Rev; 1987 Dec; 1(3):186-94. PubMed ID: 2980278
    [No Abstract]   [Full Text] [Related]  

  • 36. [Particle formation in disposable systems for the V.50.1 (Haemonetics) cell separator].
    Misterek J; Mueller-Eckhardt C
    Beitr Infusionsther; 1991; 28():159-61. PubMed ID: 1725614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experience of computer-aided management of hemapheresis unit.
    Scarpato N; Falco C; Nappi G; Formisano S
    Int J Artif Organs; 1993 Dec; 16 Suppl 5():152-4. PubMed ID: 8013977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety of donating multiple products in a single apheresis collection: are we expecting too much?
    Strauss RG
    J Clin Apher; 2003; 18(3):135-40. PubMed ID: 14569607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Therapeutic hemapheresis].
    Taraldsrud E; Aandahl GS; Stavem K; Kvalheim G; Jørstad S
    Tidsskr Nor Laegeforen; 2003 Sep; 123(17):2439-42. PubMed ID: 14594145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparative analysis of collecting mononuclear cells from peripheral blood by using Fenwal CS-3000 plus, haemonetics MCS plus and COBE spectra separators].
    Zhou WL; Hao YW
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):1103-8. PubMed ID: 25130837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.